China Resources Medical Holdings Company Limited (F:1PH) — Market Cap & Net Worth
Market Cap & Net Worth: China Resources Medical Holdings Company Limited (1PH)
China Resources Medical Holdings Company Limited (F:1PH) has a market capitalization of $354.05 Million (€302.84 Million) as of September 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #14134 globally and #1430 in its home market, demonstrating a -5.80% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying China Resources Medical Holdings Company Limited's stock price €0.26 by its total outstanding shares 1264464300 (1.26 Billion). Also see China Resources Medical Holdings Company asset portfolio for a full breakdown of the balance sheet.
China Resources Medical Holdings Company Limited Market Cap History: 2015 to 2026
China Resources Medical Holdings Company Limited's market capitalization history from 2015 to 2026. Data shows change from $304.82 Million to $384.36 Million (-1.51% CAGR). Also see 1PH cash generation efficiency for how efficiently the company converts equity into cash flow.
China Resources Medical Holdings Company Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how China Resources Medical Holdings Company Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 1PH live share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.06x
China Resources Medical Holdings Company Limited's market cap is 0.06 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1.03x
China Resources Medical Holdings Company Limited's market cap is 1.03 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $430.92 Million | $1.53 Billion | -$1.51 Billion | 0.28x | N/A |
| 2017 | $411.56 Million | $1.88 Billion | $421.03 Million | 0.22x | 0.98x |
| 2018 | $239.63 Million | $2.06 Billion | $430.90 Million | 0.12x | 0.56x |
| 2019 | $275.85 Million | $2.12 Billion | $390.87 Million | 0.13x | 0.71x |
| 2020 | $493.16 Million | $2.75 Billion | $310.13 Million | 0.18x | 1.59x |
| 2021 | $406.68 Million | $4.45 Billion | $417.92 Million | 0.09x | 0.97x |
| 2022 | $701.15 Million | $5.62 Billion | $138.97 Million | 0.12x | 5.05x |
| 2023 | $581.86 Million | $10.11 Billion | $257.68 Million | 0.06x | 2.26x |
| 2024 | $712.54 Million | $9.85 Billion | $565.88 Million | 0.07x | 1.26x |
| 2025 | $508.53 Million | $9.18 Billion | $495.94 Million | 0.06x | 1.03x |
Competitor Companies of 1PH by Market Capitalization
Companies near China Resources Medical Holdings Company Limited in the global market cap rankings as of September 18, 2026. Review China Resources Medical Holdings Company (1PH) tangible net worth to assess the quality of the company's equity after excluding intangible assets.
Key companies related to China Resources Medical Holdings Company Limited by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #289 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #915 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #999 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1235 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #289 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $429.04 |
| #915 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €46.12 |
| #999 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1235 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $261.90 |
China Resources Medical Holdings Company Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, China Resources Medical Holdings Company Limited's market cap moved from $304.82 Million to $ 384.36 Million, with a yearly change of -1.51%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €384.36 Million | -24.42% |
| 2025 | €508.53 Million | -28.63% |
| 2024 | €712.54 Million | +22.46% |
| 2023 | €581.86 Million | -17.01% |
| 2022 | €701.15 Million | +72.41% |
| 2021 | €406.68 Million | -17.54% |
| 2020 | €493.16 Million | +78.78% |
| 2019 | €275.85 Million | +15.11% |
| 2018 | €239.63 Million | -41.77% |
| 2017 | €411.56 Million | -4.49% |
| 2016 | €430.92 Million | +41.37% |
| 2015 | €304.82 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of China Resources Medical Holdings Company Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $354.05 Million USD |
| MoneyControl | $354.05 Million USD |
| MarketWatch | $354.05 Million USD |
| marketcap.company | $354.05 Million USD |
| Reuters | $354.05 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About China Resources Medical Holdings Company Limited
China Resources Medical Holdings Company Limited, an investment holding company, provides general healthcare, hospital management, and other hospital-related services in the People's Republic of China. It operates through two segments Hospital and Other Business. The Hospital segment offers out-patient and in-patient business corresponding to self-owned hospitals. The Other Business segment offer… Read more